TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors.

Omid Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.